In conclusion, the upregulation of hsa-miR-134-5p exerts inhibitory effects on the proliferation, migration, and invasion of U251 and U87 cells through modulation of the BDNF/ERK1/2 signaling pathway, thereby playing a crucial role in suppressing glioma occurrence and progression. The gene discussed is MAPK3; the disease is central nervous system cancer.